eTheRNA immunotherapies is a clinical-stage Belgian biotech company applying mRNA based immunotherapies for the treatment of cancer and infectious diseases. eTheRNA was established in January 2013 as a spin-off company of the ‘Vrije Universiteit Brussel’ (VUB), following the development of the TriMix technology by the VUB Laboratory for Molecular and Cellular Therapy. In March 2016, […]


Beta-Cell brings a ground-breaking cure for insuline-dependant type 1 diabetes within reach. Beta-Cell is a Belgian biotech company that is developing an innovative cell replacement therapy for insulin-dependent type 1 diabetes (T1D) patients that experience no benefit from current therapeutic options. As a spin-off from the internationally renowned Diabetes Research Centre (Brussels University VUB), led […]



The aim of Casc8 is to provide patients suffering from heart failure with an autologous batch of ‘in vitro’ expanded cardiac progenitor cells in order to regenerate the lost cardiac tissue. Thusfar, attempts to regenerate lost cardiac tissue have remained elusive. Contemporary drugs and interventions are not able to reverse decreased heart function and progression […]


anicells, an accelerator platform for cell therapy products, aims to facilitate the go-to-patient process of cell therapy products. Today, cell therapy is at the cutting edge of development. The use of living cells from a patient or healthy donors as a medicine has the potential to improve the lives of patients suffering from serious conditions […]